Mary Looby (@maryloobypharmd) 's Twitter Profile
Mary Looby

@maryloobypharmd

Critical Care / Anticoagulation Clinical Pharmacy Specialist | CVICU | Inova Heart and Vascular Institute

ID: 497344179

calendar_today19-02-2012 22:00:02

195 Tweet

109 Followers

373 Following

Mary Looby (@maryloobypharmd) 's Twitter Profile Photo

Such a great leader and advocate in cardiac surgery and beyond. I’m fortunate to have had the opportunity to learn from him for the past 9 years. Well deserved👏🏻👏🏻👏🏻

Mary Looby (@maryloobypharmd) 's Twitter Profile Photo

Yessss. Felt like we were in a tough spot with RED VELVT signaling we need to use VKA for LVT. Great to have a controlled trial to clarify/correct this. 👏🏻

Mary Looby (@maryloobypharmd) 's Twitter Profile Photo

In the NEJM article they state low dose heparin (LMWH) DECREASED platelet activation and that PF4 activation was independent of heparin. I’m puzzled by why the authors concluded heparin can’t be used. No SRA to corroborate a functional heparin rxn.

Mary Looby (@maryloobypharmd) 's Twitter Profile Photo

Upstream Xa inhibition preventing thrombin generation proving to be 🔑... dabig failed in VADs and mechanical valves (RE-ALIGN). More potential for Xa inhibitors based on case series in VADs and ongoing PROACT Xa (apix w/ On-X valve). Can we ⬇️ GIB in VADs with this approach?🤞🤞

Palak Shah (@palakshahmd) 's Twitter Profile Photo

Happening now #ISHLT2021, UNC 90-pt study, no ASA in #LVAD patients from implant reduces hemocompatibility related adverse events. 6-fold higher risk of bleeding with ASA, no increase in stroke. @bradbumm Nir Uriel, MD MSc Jennifer Cowger @manreetkanwar Rebecca Cogswell Khue Ton

Happening now #ISHLT2021, UNC 90-pt study, no ASA in #LVAD patients from implant reduces hemocompatibility related adverse events. 6-fold higher risk of bleeding with ASA, no increase in stroke. @bradbumm <a href="/NirUrielMD/">Nir Uriel, MD MSc</a> <a href="/preventfailure/">Jennifer Cowger</a> @manreetkanwar <a href="/rcogswell_umn/">Rebecca Cogswell</a> <a href="/tonkhueMdPhd/">Khue Ton</a>
Mary Looby (@maryloobypharmd) 's Twitter Profile Photo

Will we soon have safer antithrombotic options for LVAD patients? #ARIES says yes to aspirin withdrawal #DOACLVAD investigates apixaban in #HM3